NK-cell enhancement: TRAIL variant Published 2020-05-21 Download video MP4 360p Recommendations 04:00 Immunotherapies for the treatment of high-risk MM 35:26 Ron Vale (UCSF, HHMI) 1: Molecular Motor Proteins 13:39 Water, Cells, and Life | Dr. Gerald Pollack | TEDxNewYorkSalon 04:32 CRISPR: Gene editing and beyond 54:01 Aspirin and cancer: the emerging evidence 16:10 From Vampires to Stem Cells and Exosomes: The Human Quest for Longevity | Tunc Tiryaki | TEDxAthens 02:04 The STARGLO trial: glofitamab in combination with gemcitabine and oxaliplatin in R/R DLBCL 02:54 Mock Oxford interview at Somerville College: Biology 01:06 If our DNA is 99.9% the same as everyone else's, how can we find differences? 58:07 Real-Time PCR in Action 24:07 Sjogren's Syndrome Affects the Brain and Spine 06:38 How to tackle discrimination against the unattractive? 04:36 EHA 2024 | The DREAMM-8 study 01:27 Finite therapies with the combination of BTKIs and venetoclax in CLL 03:37 EHA2024 |The IMROZ study 08:53 Bone Marrow Biopsy Experience & Saying NO to students | Cancer Survival 05:31 What are the key diagnostic criteria for confirming MGUS? 02:12 EHA 2024 | DREAMM 7 study 01:30 Professor Matthew Costa talks about the UK STAR trial for treatment of Achilles tendon rupture 25:57 Oxford University Law Interview - Law Faculty Similar videos 27:34 Automated manufacturing of CAR NK cells [WEBINAR] 54:44 Webinar - Development of a Selective CD16a-Based NK Cell Engager 29:36 Clinical Development of NK Cell Cancer Therapy 38:16 Off-the-shelf NK cell therapy [WEBINAR] 1:01:45 Serum-free Expansion of NK Cells with K562- Based Feeder Systems for Clinical Applications 1:17:11 Engineering iPSC-derived Natural Killer Cells for Enhanced Efficacy of Cancer Therapies 20:14 Understanding Natural Killer Cells in Cancer Immunotherapies 07:42 Fate Therapeutics' FT536 and FT819 Brief Overview 02:01 Cellular therapy: NK-cells as a model 02:17 Antibody Dependent Enhancement: What Is It? Does it Occur With COVID 19 Vaccines? 44:30 Large Scale Genome Editing of Primary Human Natural Killer (NK) Cells 56:58 Translatable Efficacy & Safety Testing of mAb, Bispecific, & CAR T Therapies 40:39 Antibody Dependent Enhancement (ADE) after Vaccination (In-vitro study) 00:37 Body's natural killer cells don't function properly when infected with COVID-19: Research 39:30 Howard Chang (Stanford, HHMI) 1: Epigenomic Technologies 01:34 NK-CAR immunotherapy: where are we now? 31:10 New Horizons in Cellular Therapy: Harnessing Our Body's Natural Killer Cells to Fight Cancer 03:42 Anti-CD38 CAR NK-cells: an off-the shelf therapy for multiple myeloma More results